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We completed ﬁne mapping of nine positional candidate regions for attention-deﬁcit/hyperactivity disorder (ADHD)
in an extended population sample of 308 affected sibling pairs (ASPs), constituting the largest linkage sample of
families with ADHD published to date. The candidate chromosomal regions were selected from all three published
genomewide scans for ADHD, and ﬁne mapping was done to comprehensively validate these positional candidate
regions in our sample. Multipoint maximum LOD score (MLS) analysis yielded signiﬁcant evidence of linkage on
6q12 (MLS 3.30; empiric ) and 17p11 (MLS 3.63; empiric ), as well as suggestive evidence onPp .024 Pp .015
5p13 (MLS 2.55; empiric ). In conjunction with the previously reported signiﬁcant linkage on the basisPp .091
of ﬁne mapping 16p13 in the same sample as this report, the analyses presented here indicate that four chromosomal
regions—5p13, 6q12, 16p13, and 17p11—are likely to harbor susceptibility genes for ADHD. The reﬁnement of
linkage within each of these regions lays the foundation for subsequent investigations using association methods
to detect risk genes of moderate effect size.
Attention-deﬁcit/hyperactivity disorder (ADHD [MIM
143465]) is one of the most commonly diagnosed neu-
robehavioral disorders of childhood, affecting ∼5%–7%
of children and ∼3% of adults (Wolraich et al. 1996;
McCracken 1998; Swanson et al. 1998). ADHD is de-
ﬁned as the childhood onset of multiple symptoms of
inattention and/or hyperactivity-impulsivity leading to
signiﬁcant impairment in at least two settings (American
Psychiatric Association 1994). Heritability estimates in
the range of 60%–90% (Levy et al. 1997; Faraone and
Doyle 2001), sibling relative risk estimates (ls) in the
range of 4–8 (Smalley 1997; Faraone et al. 2000), and
consistent prevalence rates across diverse regions of the
world (Anderson et al. 1987; Gomez et al. 1999; Tahir
et al. 2000; Wilens et al. 2002) suggest a strong genetic
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etiology.
The vast majority of molecular genetic studies of
ADHD have been predicated on the detection of asso-
ciation between ADHD and the allelic variants of func-
tional candidates. The selection of functional candidates
has relied on assumptions about the molecular mecha-
nisms underlying ADHD and has been generally con-
strained to the most obvious genes integral to the do-
paminergic, serotonergic, and adrenergic pathways. This
approach is fundamentally limited by our current un-
derstanding of the pathways involved in this disorder,
as well as the molecular components of a given pathway.
Although positive associations with polymorphisms near
or within the dopamine transporter gene (DAT-1), do-
pamine receptor D4 gene (DRD4), and dopamine re-
ceptor D5 gene (DRD5) have been reproduced in in-
dependent studies, failures to replicate these results in
adequately sized populations are also evident (Palmer et
al. 1999; Holmes et al. 2000), and the purported effect
sizes are small (Cook et al. 1995; LaHoste et al. 1996;
Gill et al. 1997; Smalley et al. 1998; Daly et al. 1999;
McCracken et al. 2000; Faraone et al. 2001; Mill et al.
2001; Lowe et al. 2004). Other candidate genes have
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been the subject of fewer investigations, and both pos-
itive and negative ﬁndings are reported (Barr et al. 2000;
Brophy et al. 2002; Kustanovich et al. 2003).
Although the pooling of resources within the ADHD-
genetics community may improve the power to detect
subtle associations, the effect of such alleles is proving
to be small (Lowe et al. 2004). Genomewide linkage
methods provide a complementary and powerful ap-
proach to candidate-gene studies, because they do not
rely on prior knowledge of the molecular etiology, and
novel genes may be identiﬁed through positional cloning.
Three genomewide linkage scans of ADHD have been
published to date with the use of affected sibling pair
(ASP) sampling (Fisher et al. 2002; Bakker et al. 2003;
Ogdie et al. 2003). The ﬁrst genomewide scan was con-
ducted on 126 ASPs (Fisher et al. 2002) and identiﬁed
four nominal regions (5p12, 10q26, 12q23, and 16p13)
with multipoint maximum LOD scores (MLSs) 11.5, but
none exceeded recommended thresholds for suggestive
or signiﬁcant linkage. A second genomewide scan in an
independent set of 101 families was pooled with this
initial group of 126 ASPs (270 ASPs total), and six chro-
mosomal regions were identiﬁed with MLS values 11
(5p13, 6q14, 11q25, 16p13, 17p11, and 20q13), with
one region exceeding suggestive evidence of linkage
(17p11; MLS 2.98) (Ogdie et al. 2003). An independent
team of investigators (Bakker et al. 2003) completed a
genomewide scan of 164 Dutch ASPs with ADHD and
presented evidence for four strong-candidate chromo-
somal locations (7p13, 9q33, 13q33, and 15q15), with
overlap of only one nominally signiﬁcant region (5p13)
across the scans.
Fine mapping of the 16p13 region highlighted in our
genomewide scans was completed and described else-
where in an extended sample, and results of that analy-
sis demonstrated genomewide signiﬁcance under both
theoretical and empirical criteria (MLS 3.73; empiric
) (Ogdie et al. 2003; Smalley et al. 2002). InPp .01
this report, we describe ﬁne mapping of nine additional
regions in an extended sample of 308 ASPs. The nine
regions included ﬁve selected on the basis of our ge-
nomewide linkage analyses (5p13, 6q12/6q14, 11q25,
17p11, and 20q13) and the four strongest regions iden-
tiﬁed in the Dutch sample (7p13, 9q33, 13q33, and
15q15) (Bakker et al. 2003).
The sample of 308 ASPs with ADHD is derived from
226 multiplex families (194 two-sib families, 26 three-
sib families, and 6 four-sib families), containing a total
of 490 affected children and 308 ASPs (all possible
pairs). The current sample contains 269 of the 270 ASPs
reported in the previous genomewide scans (Fisher et al.
2002; Ogdie et al. 2003) and an independent set of 39
ASPs. Parents of all ASPs were genotyped, with both
parents available for 289 (94%) ASPs and one parent
available for 19 (6%) ASPs. The affected individuals in
the sample are 73% male, 78% white, and fairly rep-
resentative of the subtype proportions evident in epi-
demiological studies of ADHD (49% combined, 44%
inattentive, and 7% hyperactive-impulsive) (Wolraich et
al. 1996). ADHD was diagnosed in accordance with
DSM-IV criteria, by use of a best-estimate procedure
(American Psychiatric Association 1994). A deﬁnite
ADHD diagnosis was made for 95% of the ASP mem-
bers, whereas a probable ADHD diagnosis (i.e., the in-
dividual showed one less symptom than the diagnosis
requirement but met criteria of impairment and age at
onset) was made in 5% of the sample. All ASPs have at
least one member with a deﬁnite diagnosis. Details of
the sample characteristics are published elsewhere (Smal-
ley et al. 2000). Expected psychiatric comorbidity is pre-
sent in the sample and includes oppositional-deﬁant dis-
order (46%), conduct disorder (11%), mood disorders
(major depression, dysthymia, and bipolar disorder)
(17%), and anxiety disorders (8%). Although ﬁve of the
ASP members had a comorbid diagnosis of bipolar dis-
order, none came from the same family. We tested the
impact these cases might have had on the MLS results
by removing them from the data set and rerunning the
MLS analysis. There were no signiﬁcant changes in the
MLS values for any of the chromosomes of interest in
the sample from which the ﬁve cases were excluded.
The nine chromosomal regions selected for ﬁne map-
ping (table 1) were deﬁned by the 1-LOD support in-
tervals of the linkage peaks presented in the genomewide
scans. For the ﬁve candidate regions identiﬁed in our
sample (5p13, 6q14, 11q25, 17p11, and 20q13), we
selected microsatellite markers to create an ∼2-cM grid
across the 1-LOD support intervals (12–19 markers per
region). For the four candidate regions identiﬁed in the
Dutch cohort, we selected microsatellite markers to cre-
ate an ∼3-cM grid across the 1-LOD support intervals
(8–10 markers per region). The genetic positions of all
markers were initially determined using the deCODE
high-resolution map (Kong et al. 2002) and Marshﬁeld
(Center for Medical Genetics) genetic maps and were
validated by mapping procedures within our own data
set by use of ASPEX v. 2.3 sib_map (Hinds and Risch
1996). In addition, the physical-mapping positions and
order of all markers were veriﬁed with both the Uni-
versity of California–Santa Cruz (UCSC) genome da-
tabase build hg16 and the National Center for Biotech-
nology Information (NCBI) build 34. Genotyping was
performed in accordance with standard procedures
(Ogdie et al. 2003). Mendelian inheritance errors were
identiﬁed and removed using GAS 2.0 (A. Young, Ox-
ford University), and improbable genotypes, as deter-
mined by the presence of unlikely recombination events,
were identiﬁed and removed using Simwalk2 (Sobel and
Lange 1996).
Multipoint MLS analysis (Risch 1990) was conducted
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Table 1
Multipoint MLS Values in Chromosomal Regions of Fine Mapping
CHROMOSOME MARKERa
LOCATION
MLS
P
Cytogeneticb
Geneticc
(cM) Nominald Empirice
5 D5S418 5p13 59 2.55 .00058 .091
6 D6S430 6q12 83 3.30 .000098 .024
7 D7S1818 7p13 69 .00 .60 1.000
9 D9S1825 9q33 136 .00 .60 1.000
11 D11S4126 11q25 173 1.00 .026 .931
13 D13S796 13q33 94 .84 .039 .972
15 D15S146 15q15 35 .28 .18 1.000
16f D16S3114 16p13 23 3.73 .000035 .012
17 D17S947 17p11 38 3.63 .000045 .015
20 D20S1106 20q13 101 1.09 .020 .871
a Marker nearest to the center of the 1-LOD support interval.
b Approximate cytogenetic position, as determined by physical mapping of markers
under a 1-LOD support interval.
c The approximate Marshﬁeld genetic position of the center of the 1-LOD support
interval. For the four Utrecht regions presenting MLSs !1 (7p, 9q, 13q, and 15q), the listed
genetic position was determined by the center of the ﬁne-mapping marker panel.
d LOD scores were converted into nominal pointwise P values: 2P(LOD)p .5# (x 11
(Nyholt 2000).22 ln10# LOD) .098# (x 1 2 ln10# LOD)2
e Approximate empiric P values were determined from 1,000 replicates of the genome-
wide data set under the null hypothesis at an artiﬁcially high density of one marker every
2 cM across the genome. Calculated as , where x is the number of inde-(x 1)/(n 1)
pendent regions of linkage presenting an MLS greater than or equal to the threshold and
n is the number of replicates. For peaks yielding MLS values that occurred more frequently
than once per replicate, the P value was calculated as , where r is the number(r 1)/(n 1)
of replicates yielding an MLS greater than or equal to the threshold (7p, 9q, 11q, 13q,
15q, and 20q).
f Data for 16p13 was published elsewhere by Ogdie et al. (2003) and is presented here
for reference.
by ASPEX sib_ibd v. 2.3 (Hinds and Risch 1996), under
the multiplicative model with parameters restricted to
the possible triangle (Holmans 1993). MLSs were cal-
culated at 1-cM increments, with all possible pairs
treated as independent. Single-point MLS analysis was
performed by Genehunter v. 2.1 with the use of Map-
maker/Sibs commands (Kruglyak and Lander 1995; see
Kruglyak Laboratory and Mapmaker/Sibs Web sites).
ASPEX sib_ibd uses only fully informative transmis-
sions, whereas single-point MLS analysis in Genehunter
uses all inheritance information for the reconstruction
of missing parental genotypes and for the determination
of identity-by-descent (IBD) and thus maximizes the
number of ASPs contributing to a single-point MLS.
MLS values were converted to pointwise P values by the
derivation for MLS calculated under the possible tri-
angle: 2P(LOD)p .5# (x 1 2 ln 10# LOD) .098#1
(Holmans 1993; Nyholt 2000). In2(x 1 2 ln 10# LOD)2
accordance with convention, we have deﬁned the nom-
inal threshold as a pointwise P value !.05. To estimate
empiric P values, simulations were performed using the
unique parameters of the current data set, including
marker parameters, pedigree structure, and missing ge-
notypes. The purpose of the current simulations is to
estimate a threshold of signiﬁcance that accounts for
genomewide sampling (i.e., an MLS equivalent to Pp
or an event likely to randomly occur once in 20.05
genomewide scans) and to estimate how often onewould
encounter an independent region of linkage with anMLS
exceeding a particular level in a genomewide scan. The-
oretically derived thresholds of signiﬁcance do not ac-
count for missing data points, uninformative markers,
or the variable density of markers employed in linkage
studies. A total of 1,000 replicates of the genomewide
data were generated under the null hypothesis of no
linkage, by use of Simulate 2.4 (Terwilliger et al. 1993),
and were analyzed by the same procedures as the actual
data set. Simulate 2.4 distributes alleles among the foun-
ders of each pedigree on the basis of the allele frequencies
present in the real data set, creates recombination events
on the basis of the probabilities deﬁned by the marker
maps, and randomly transmits chromosomes to progeny.
We generated replicates of the data set at an artiﬁcially
high genomewide density of one marker every 2 cM,
accounting for the assumption that ﬁne mapping within
this sample will continue in the future. The empiric P
values presented in this study are intended to estimate
the likelihood of observing a given MLS value in a 2-
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cM genomewide scan performed in a sample of 308ASPs
without linkage to a disease.
Multipoint MLS analysis yielded signiﬁcant evidence
of linkage for the regions on 6q12-6q14 (MLS 3.30;
empiric ) and 17p11 (MLS 3.63; empiricPp .024
) (table 1 and ﬁg. 1). Region 5p13, the onlyPp .015
region presenting evidence of linkage in both our sample
and the Dutch sample, yielded suggestive evidence (MLS
2.55; empiric ). Evidence of linkage to 11q25Pp .091
(MLS 1.00; empiric ) and 20q13 (MLS 1.09;Pp .931
empiric ) remained below the suggestive thresh-Pp .871
old and did not increase above that of the 10-cM data
set. Region 13q33 yielded evidence of linkage above the
nominal threshold (MLS 0.84; pointwise ; em-Pp .039
piric ), whereas analysis of the other threePp .972
regions identiﬁed by Bakker et al. (2003) failed to yield
even nominal evidence of linkage in our sample and did
not vary appreciably from the evidence provided by our
10-cM data set, indicating that the 10-cM genomewide
scan provided an accurate estimate of IBD sharing in
these unlinked regions (table 1 and ﬁg. 1). To assess the
evidence of linkage present in the independent set of 39
ASPs—included in the current study and absent from
the previously reported genomewide scans—we per-
formed a separate multipoint MLS analysis of this in-
dependent set. Although the sample of 39 independent
ASPs is not large enough to demonstrate statistical sig-
niﬁcance comparable to the samples described in the
genomewide scans (Fisher et al. 2002; Ogdie et al. 2003),
the trend of excess sharing continues, and evidence of
linkage is present: 5p13 (sharing 63.55%, MLS 0.22),
6q12 (sharing 70.09%, MLS 1.27), and 17p11 (sharing
59.79%, MLS 0.18). Thus, the increased evidence of
linkage is the result of both greater marker density and
the expansion of the sample size. Results from single-
point MLS analyses were highly consistent with multi-
point ﬁndings (table 2). Of note, in ﬁne-mapping regions
on chromosomes 5, 6, and 17, several markers yielded
MLSs 11 under each peak (three markers in 5p13, seven
markers in 6q12, and nine markers in 17p11).
The MLS analysis presented here, in conjunction with
previously published work (Smalley et al. 2002), strongly
supports four chromosomal regions (5p13, 6q12, 16p13,
and 17p11) as likely candidate locations of susceptibility
loci for ADHD. The 5p13 region is highlighted, despite
not reaching genomewide signiﬁcance, because of the
overlap of this region with that presented by the inde-
pendent scan in the sample of Dutch ASPs (MLS 1.43)
(Bakker et al. 2003). The estimated IBD sharing pa-
rameters for all four regions indicate loci of moderate
effect size, with ls in the range of 1.4–1.6, under a
multiplicative model with a recombination fraction of
zero ( ) (Risch 1990). The current analysis elim-vp 0
inates the possibility that our failure to detect linkage in
the four major regions identiﬁed in the Dutch study is
the result of poor coverage. The present study does not
address the lack of linkage detected in the Dutch sample
for 6q12, 16p13, and 17p11. To assess the likelihood
of observing three linkage peaks above the threshold of
signiﬁcance, we assumed a Poisson distribution (Lander
and Kruglyak 1995; Wiltshire et al. 2002) and derived
a posterior probability of this event under the null hy-
pothesis. The cumulative Poisson distribution indicates
that the probability of observing the three signiﬁcant
linkage peaks within this sample is !2.3#106, strongly
suggesting that at least one susceptibility gene is located
in one of these three regions (6p12, 16p13, and 17p12).
The region on 5p13 is centered at D5S418 (58 cM,
Marshﬁeld; 40 Mb, UCSC hg16), with a 1-LOD support
interval spanning ∼7 cM (15 Mb) from D5S2105 to
D5S1968. Fine mapping of 5p13 resulted in an increase
from anMLS of 1.77 to anMLS of 2.55 and signiﬁcantly
narrowed the 1-LOD support interval from ∼20 cM to
∼7 cM. The region on 6q12-6q14 is centered at D6S430
(81 cM, Marshﬁeld; 67 Mb, UCSC hg16), with a 1-
LOD support interval spanning ∼18 cM (33 Mb) from
D6S465 to D6S1609 and a maximum MLS value on
6q14 (∼89 cM, D6S460). The ﬁne-mapping data in-
creased the MLS from 1.75 to 3.30 and reduced the 1-
LOD support interval by 12 cM. Note that the gene
encoding serotonin receptor 1B (HTR1B) is directly un-
der the maximum MLS (89 cM), and the gene encoding
serotonin receptor 1E (HTR1E) resides just outside of
the 1-LOD q-boundary. Elsewhere, Quist et al. (2003)
have reported a trend toward excess transmission of a
polymorphism in HTR1B in a sample of 115 families
with ADHD ( ). The region on 16p13 is centeredPp .09
at D16S3060 (28 cM, Marshﬁeld; 12 Mb, UCSC hg16),
with a 1-LOD support interval spanning ∼12 cM (7Mb)
from D16S519 to D16S499, and overlaps a region high-
lighted in genomewide scans for autism (Smalley et al.
2002). The 1-LOD support interval on 17p11, centered
at D17S839 (37 cM, Marshﬁeld; 14 Mb, UCSC hg16)
and spanning ∼20 cM (25 Mb) across the centromere
from D17S947 to D17S798, also overlaps with two ge-
nomewide scans in autism (International Molecular Ge-
netic Study of Autism Consortium 2001; Yonan et al.
2003). Fine mapping of this region increased the evi-
dence of linkage from an MLS of 2.98 to an MLS of
3.63 and reﬁned the 1-LOD support interval by 5 cM.
The gene encoding serotonin transporter (5-HTT), a
commonly cited functional candidate for both ADHD
and autism, is located on 17q11 within the q-boundary
of the 1-LOD support interval. Manor et al. (2001) re-
ported an association between ADHD and a promo-
ter polymorphism in 5-HTT (5-HTTLPR) in 98 trios
( ). In addition, Seeger et al. (2001) have re-Pp .008
ported an association between hyperkinetic disorder and
the 5-HTTLPR long variant ( ). These fourPp .009
regions do not contain the most commonly studied func-
Figure 1 Multipoint MLS values for nine candidate regions in 308 ASPs with ADHD. The X-axis values are distances from the p-telomere, in Kosambi cM. The MLS values for the
10-cM genomewide scan of 270 ASPs (Ogdie et al. 2003) are shown in red. The ﬁne-mapping values, at ∼ 2-cM marker density in candidate regions, are shown in blue. The blue bar indicates
the approximate ﬁne-mapping interval. The identical MLS values for the 2-cM and 10-cM analyses for chromosomes 7 and 9 and a large portion of chromosome 15 give the appearance of
a single line. MLS analysis was performed by ASPEX sib_ibd, under the possible triangle.
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Table 2
Markers Yielding Single-Point MLS 11 in Fine-Mapping Regions
CHROMOSOME
AND MARKER
LOCATION
HETEROZYGOSITYa
(%) MLS NOMINAL PbCytogeneticc
Geneticd
(cM)
5:
D5S418 5p13 58.6 80 3.24 .00011
D5S1958 5p12 59.9 58 1.24 .014
D5S1968 5q11 60.9 77 1.26 .013
6:
D6S465 6p12 74.3 75 2.46 .00072
D6S1960 6p12 76.6 74 1.05 .022
D6S257 6p12 79.9 87 1.83 .0033
D6S430 6q12 81.5 83 1.72 .0043
D6S1557 6q13 82.6 76 1.97 .0023
D6S460 6q14 89.8 81 1.06 .022
D6S1609 6q14 92.3 80 1.50 .0074
11:
D11S4126 11q25 138.6 54 1.19 .016
16e:
D16S3114 16p13 23.3 79 1.74 .0041
D16S3060 16p13 28.3 81 1.42 .0090
17:
D17S947 17p12 32.0 76 1.72 .0043
D17S799 17p12 32.1f 90 1.54 .0067
D17S1856 17p12 35.6 81 2.51 .00064
D17S839 17p11 37.8 64 1.84 .0032
D17S953 17p11 43.0 68 1.23 .014
D17S1857 17p11 43.1f 71 2.06 .0019
D17S2196 17p11 44.6 84 1.70 .0045
D17S1824 17q11 49.7 82 1.35 .011
D17S798 17q11 53.4 74 1.41 .0092
20:
D20S1106 20q13 101.2f 71 2.11 .0017
a Heterozygosity calculated from the entire study sample.
b LOD scores were converted into nominal pointwise P values: 2P(LOD)p .5# (x 11
(Nyholt 2000).22 ln10# LOD) .098# (x 1 2 ln10# LOD)2
c Approximate cytogenetic position, as determined by physical mapping of markers
under 1-LOD support interval.
d The approximate Marshﬁeld genetic position of the marker.
e Data for 16p13 was published elsewhere by Ogdie et al. (2003), and we have presented
two markers here for reference.
f The genetic position was estimated from physical-mapping position and/or deCODE.
tional candidate genes, highlighting the importance of
genomewide linkage strategies for complex traits.
In conclusion, we have deﬁned three genomic regions
yielding empirically signiﬁcant linkage to ADHD (6q12,
16p13, and 17p11) and a fourth region yielding sug-
gestive evidence (5p13). Association studies (e.g., with
the use of high-density–SNP data) constitute a viable and
realistic strategy for the identiﬁcation of causal poly-
morphisms in these regions. From the predicted ls values
(1.4–1.6) observed in our ﬁne-mapping studies, the ge-
notype relative risks are estimated to be 13 (Risch and
Merikangas 1996), indicating that a sample of 170 trios
would provide adequate power for the detection of com-
mon effect alleles. Replication of linkage in these regions
in an independent sample would provide an important
validation. Thus, ongoing collection of ADHD samples
is critical for the replication of both linkage and asso-
ciation, given the genetic heterogeneity demonstrated by
the discordance of linkage studies and the small popu-
lation–attributable risks found for previously associated
polymorphisms. Finally, the reﬁnement of phenotypes
and trait measures more closely reﬂecting the true bio-
logical underpinnings may greatly facilitate efforts to
identify susceptibility genes for ADHD.
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